Benefits of topical product evaluated in patients undergoing laser treatment

The use of a combination product applied to treated areas before and after laser treatment of the face or decollete appeared to improve healing, compared with standard care, in a split-face study of 10 patients undergoing fractional CO₂ laser treatment of the face and decollete.

The results were presented in a poster at the Summit in Aesthetic Medicine held by Global Academy for Medical Education. The product, manufactured by Alastin Skincare, is a topical formulation designed for use before and after laser therapy.

Before and after treatment, patients in the trial were given the topical treatment on one side of their faces or decollete and a standard treatment on the other, according to the poster.

Based on the blinded investigator ratings, the sides treated with the new product scored higher on day 4 for lentigines (P = .009), texture (P = .043), and Global Skin Quality (P = .051), according to Deanne Robinson, MD, director of the body sculpting center at the Connecticut Dermatology Group and the author of the study.

In addition, patients said they were more satisfied with the side treated with the product in terms of looking better and feeling better on that side (P = .05).

Dr. Robinson reported no financial conflicts. Global Academy and this news organization are owned the same company.

ezimmerman@frontlinemedcom.com

On Twitter @eaztweets